One huge reason why the world of medicine hasn't yet found "the cure" for hard-to-treat malignancies like acute myeloid leukemia (AML) and many other forms of cancer is that the world of science is ...
Q3 2025 Earnings Call October 24, 2025 8:30 AM EDTCompany ParticipantsThomas Larsen - Head of Investor RelationsPaul Hudson - CEO ...
CHICAGO -- A fixed-dose inhaler combining an inhaled corticosteroid, long-acting muscarinic antagonist, and long-acting beta agonist (ICS/LAMA/LABA) improved lung function and reduced exacerbations in ...
The "atopic march" describes the age-related progression of allergic diseases, presenting as the sequential onset of atopic ...
Incyte today announced new data from the Phase 3b TRuE-AD4 study evaluating the efficacy and safety of Opzelura® (ruxolitinib cream) in adults with moderate atopic dermatitis (AD) who had an ...
A literature review reports peer-reviewed studies associating prenatal and childhood pesticide exposure to measurable ...
According to ABC, "High Potential" is the first 10 p.m. drama to top the overall entertainment rankings since NBC’s “ER” did ...
Discover how glucocorticoid-mediated eosinopoiesis in asthma creates a paradox, influencing relapse, steroid resistance, and ...
Rates of one type of breast cancer — invasive lobular carcinoma — have been rising in the United States more than three times ...
A blood test that screens for more than 50 cancers is correct in 62% of cases where it thinks people may have the disease, a ...